Valuation: Iconovo AB

Market Cap 103M 10.82M 9.35M 8.78M 7.99M 15.02M 1.03B 15.26M 40.23M 518M 40.63M 39.75M 1.72B P/E 2026 *
-26.8x
P/E 2027 * -3.06x
Enterprise Value 63.9M 6.72M 5.8M 5.45M 4.96M 9.33M 643M 9.48M 24.99M 322M 25.23M 24.68M 1.07B EV / Sales 2026 *
2.2x
EV / Sales 2027 * -
Free-Float
39.74%
Yield 2026 *
-
Yield 2027 * -
1 day-0.47%
1 week+5.45%
Current month+3.40%
1 month+1.43%
3 months-6.58%
6 months-6.58%
Current year-6.58%
1 week 1.04
Extreme 1.035
1.1
1 month 0.87
Extreme 0.87
1.1
Current year 0.87
Extreme 0.87
1.44
1 year 0.87
Extreme 0.87
2.79
3 years 0.87
Extreme 0.87
18.5
5 years 0.87
Extreme 0.87
90
10 years 0.87
Extreme 0.87
99.8
Manager TitleAgeSince
Chief Executive Officer 59 31/10/2025
Director of Finance/CFO 63 01/04/2023
Chief Operating Officer 62 01/01/2016
Director TitleAgeSince
Chairman 65 01/01/2013
Director/Board Member 62 01/01/2013
Director/Board Member 67 01/01/2013
Date Insider Type Main position Quantity % Market Cap.
9/22/22 A Buy

Founder

500 0.0057%
9/21/22 A Buy

Chief Executive Officer

1,000 0.0113%
9/16/22 A Buy

Director

840 0.0095%
Change 5-day change 1-year change 3-year change Capi.($)
-0.47%+5.45%-46.08%-93.75% 10.82M
-1.58%-1.68%-31.05%-47.36% 14.94B
-3.07%-4.93%+27.35%+119.91% 4.61B
-0.78%-2.11%+252.70%+197.44% 3.27B
-0.92%-1.76%-28.84%-30.69% 2.51B
-0.98%-1.04%-30.87%-28.56% 1.86B
0.00%+3.97%+9.17%-18.63% 1.29B
-0.80%+0.10%+6.07%-11.78% 1.09B
-0.89%-3.42%-4.50%+13.97% 983M
-1.19%-1.78%+20.29%+31.75% 974M
Average -1.06%+1.08%+17.43%+13.23% 3.15B
Weighted average by Cap. -1.44%-1.51%+12.40%+11.65%

Financials

2026 *2027 *
Net sales 29M 3.05M 2.63M 2.48M 2.25M 4.23M 292M 4.3M 11.34M 146M 11.45M 11.2M 485M -
Net income -3M -315K -272K -256K -233K -438K -30.17M -445K -1.17M -15.11M -1.18M -1.16M -50.2M -34M -3.58M -3.09M -2.9M -2.64M -4.96M -342M -5.04M -13.29M -171M -13.42M -13.13M -569M
Net Debt -39M -4.1M -3.54M -3.33M -3.03M -5.69M -392M -5.78M -15.25M -196M -15.4M -15.06M -653M 1M 105K 90.82K 85.35K 77.62K 146K 10.06M 148K 391K 5.04M 395K 386K 16.73M
Logo Iconovo AB
Iconovo AB is a Sweden-based company, which offers inhalation solutions for pharmaceutical companies. Solutions are based on the Company’s device platforms and include formulation, analytical testing and documentation. Iconovo Ab develops products, which are a part of device family and include: ICOres, reservoir devices, ICOone, disposable unit-dose devices, ICOcap, capsule-based devices and ICOpre, pre-metered devices. Moreover, the Company offers programs, which include development of generic inhalation products, where the products are registered based on therapeutic equivalence; development of inhalation products based on a generic application programming interface (API) and new chemical entity (NCE); as well as phase I-II clinical trials using ICOone.
Employees
12
Date Price Change Volume
17/08/26 SEK 1.065 -0.47% 462
14/08/26 SEK 1.070 0.00% 4,625
13/08/26 SEK 1.070 -2.73% 52,950
12/08/26 SEK 1.100 +5.77% 43,299
11/08/26 SEK 1.040 +2.97% 24,337

Quarterly revenue - Rate of surprise